UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

Neuro-oncology (Charlottesville, Va.), 2016-04, Vol.18 (4), p.557-564

2016

Volltextzugriff (PDF)

Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma

Blood, 2018-11, Vol.132 (21), p.2240-2248

2018

Volltextzugriff (PDF)

Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo

Science translational medicine, 2015-02, Vol.7 (274), p.274ra17

2015

Volltextzugriff (PDF)

Lessons learned in the development of targeted therapy for malignant gliomas

Molecular cancer therapeutics, 2007-07, Vol.6 (7), p.1909-1919

2007

Volltextzugriff (PDF)

Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly

Journal of neuro-oncology, 2007-11, Vol.85 (2), p.207-211

2007

Volltextzugriff (PDF)

High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib

Cancer, 2005-06, Vol.103 (11), p.2344-2348

2005

Volltextzugriff (PDF)

Autologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan and cyclophosphamide

Leukemia & lymphoma, 2015-02, Vol.56 (2), p.361-367

2015

Volltextzugriff (PDF)

Pitfalls in the diagnosis of brain tumours

Lancet neurology, 2006-11, Vol.5 (11), p.937-948

2006

Volltextzugriff (PDF)

Radiotherapy Plan Quality Assurance in NRG Oncology Trials for Brain and Head/Neck Cancers: An AI-Enhanced Knowledge-Based Approach

Cancers, 2024-05, Vol.16 (11), p.2007

2024

Volltextzugriff (PDF)

Top advances of the year: Neuro‐oncology

Cancer, 2023-05, Vol.129 (10), p.1467-1472

2023

Volltextzugriff (PDF)

Continuing the search for MR imaging biomarkers for MGMT promoter methylation status: conventional and perfusion MRI revisited

Neuroradiology, 2012-06, Vol.54 (6), p.641-643

2012

Volltextzugriff (PDF)

Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer

Journal of neuro-oncology, 2010-12, Vol.100 (3), p.443-447

2010

Volltextzugriff (PDF)

Emerging therapies for glioblastoma

JAMA neurology, 2014-11, Vol.71 (11), p.1437

2014

Volltextzugriff (PDF)

Long-term Outcomes in Primary CNS Lymphoma After R-MVP and High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplant

Neurology, 2023-08, Vol.101 (7), p.e710

2023

Volltextzugriff (PDF)

Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial

Journal of clinical oncology, 2019-03, Vol.37 (9), p.741-750

2019

Volltextzugriff (PDF)

Dynamic contrast‐enhanced MRI perfusion for differentiating between melanoma and lung cancer brain metastases

Cancer medicine (Malden, MA), 2017-04, Vol.6 (4), p.761-767

2017

Volltextzugriff (PDF)

Salvage temozolomide for prior temozolomide responders

Cancer, 2005-12, Vol.104 (11), p.2473-2476

2005

Volltextzugriff (PDF)

Cognitive functions in primary CNS lymphoma after single or combined modality regimens

Neuro-oncology (Charlottesville, Va.), 2012-01, Vol.14 (1), p.101-108

2012

Volltextzugriff (PDF)

Overall survival in patients with glioblastoma before and after bevacizumab approval

Current medical research and opinion, 2018-05, Vol.34 (5), p.813-820

2018

Volltextzugriff (PDF)

Leptomeningeal Metastasis from Non-small Cell Lung Cancer: Survival and the Impact of Whole Brain Radiotherapy

Journal of thoracic oncology, 2012-02, Vol.7 (2), p.382-385

2012

Volltextzugriff (PDF)

Second‐opinion interpretations of neuroimaging studies by oncologic neuroradiologists can help reduce errors in cancer care

Cancer, 2016-09, Vol.122 (17), p.2708-2714

2016

Volltextzugriff (PDF)

MRI perfusion in determining pseudoprogression in patients with glioblastoma

Clinical imaging, 2013-01, Vol.37 (1), p.41-49

2013

Volltextzugriff (PDF)

Delayed neurotoxicity in primary central nervous system lymphoma

Archives of neurology (Chicago), 2005-10, Vol.62 (10), p.1595

2005

Volltextzugriff (PDF)

Erdheim–Chester Disease Presenting With Diplopia: A Challenging Diagnosis With Effective Treatment

Journal of neuro-ophthalmology, 2021-09, Vol.41 (3), p.e324-e325

2021

Volltextzugriff (PDF)

What is the relevance of determining EGFR-variant-III status in glioblastomas?

Nature clinical practice. Oncology, 2008-04, Vol.5 (4), p.188-189

Omuro, Antonio MP

2008

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

Englisch
(110)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(74)
Science & Technology
(74)
Humans
(68)
Male
(52)
Oncology
(51)
Female
(49)
Middle Aged
(48)
Aged
(44)
Adult
(40)
Neurosciences & Neurology
(36)
Clinical Neurology
(35)
Aged, 80 And Over
(19)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(19)
Treatment Outcome
(19)
Chemotherapy
(17)
Neurology
(16)
Prognosis
(16)
Glioblastoma
(15)
Magnetic Resonance Imaging
(15)
Follow-Up Studies
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Neuro-Oncology
(19)
Journal Of Clinical Oncology
(10)
Journal Of Neuro-Oncology
(8)
Blood
(6)
Cancer
(6)
Leukemia & Lymphoma
(4)
Neurology
(4)
Biology Of Blood And Marrow Transplantation
(3)
Current Opinion In Neurology
(3)
Cancers
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma

Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo

Lessons learned in the development of targeted therapy for malignant gliomas

Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly

High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib

Autologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan and cyclophosphamide

Pitfalls in the diagnosis of brain tumours

Radiotherapy Plan Quality Assurance in NRG Oncology Trials for Brain and Head/Neck Cancers: An AI-Enhanced Knowledge-Based Approach

Top advances of the year: Neuro‐oncology

Continuing the search for MR imaging biomarkers for MGMT promoter methylation status: conventional and perfusion MRI revisited

Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer

Emerging therapies for glioblastoma

Long-term Outcomes in Primary CNS Lymphoma After R-MVP and High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplant

Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial

Dynamic contrast‐enhanced MRI perfusion for differentiating between melanoma and lung cancer brain metastases

Salvage temozolomide for prior temozolomide responders

Cognitive functions in primary CNS lymphoma after single or combined modality regimens

Overall survival in patients with glioblastoma before and after bevacizumab approval

Leptomeningeal Metastasis from Non-small Cell Lung Cancer: Survival and the Impact of Whole Brain Radiotherapy

Second‐opinion interpretations of neuroimaging studies by oncologic neuroradiologists can help reduce errors in cancer care

MRI perfusion in determining pseudoprogression in patients with glioblastoma

Delayed neurotoxicity in primary central nervous system lymphoma

Erdheim–Chester Disease Presenting With Diplopia: A Challenging Diagnosis With Effective Treatment

What is the relevance of determining EGFR-variant-III status in glioblastomas?

Suchergebnisse filtern